Development of skin hypopigmentation in a patient with metastatic papillary carcinoma thyroid treated with Sorafenib

BACKGROUND: Sorafenib can be considered as the effective option of treatment in patients with metastatic radioiodine refractory differentiated thyroid cancers. The cutaneous manifestations of Sorafenib include rash, desquamation, hand foot skin reactions, pruritus, alopecia and erythema. We report t...

Descripción completa

Detalles Bibliográficos
Autores principales: Hussain, Syed Zubair, Asghar, Ali, Ikram, Mubasher, Islam, Najmul
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3750499/
https://www.ncbi.nlm.nih.gov/pubmed/23937803
http://dx.doi.org/10.1186/1472-6823-13-29

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3750499/
https://www.ncbi.nlm.nih.gov/pubmed/23937803
http://dx.doi.org/10.1186/1472-6823-13-29

Ejemplares similares